Drug intelligence / Profile preview

(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a small molecule experimental drug belonging to the pyrrolopyridine class. It acts as an inhibitor of cell division cycle 7-related protein kinase (CDC7), a kinase involved in the initiation of DNA replication by phosphorylating substrates that regulate the G1/S phase transition such as MCM proteins and CLASPIN. The inhibition of CDC7 suggests potential applications in targeting proliferative diseases like cancer. The compound has been referenced under PubMed ID 19115845 and is identified by DrugBank accession DB07149. No marketed brand names or approved indications are currently available; it remains an experimental agent primarily studied for its kinase inhibitory activity.

Other names
(7S)-2-(2-amino-4-pyrimidinyl)-7-(2-fluoroethyl)-1H,4H,5H,6H,7H-pyrrolo[3,2-c]pyridin-4-one
02

Targets

CDC7 (Cell division cycle 7-related protein kinase)

Beyond the preview

Go deeper on (7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call